Why Is Praxis Precision Stock Soaring Tuesday?

Praxis Precision Medicines Inc. (NASDAQ:PRAX) shares are up on Tuesday as the company announced FDA acceptance of its New Drug Application (NDA) for ulixacaltamide HCl, a treatment for essential tremor. Praxis Precision Medicines is a fully integrated central nervous...